The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Eric Hollander

Department of Psychiatry

Mount Sinai School of Medicine

New York

NY 10029

USA

[email]@mssm.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA. 2000 - 2008
  • Seaver and NY Autism Center of Excellence, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1230, USA. 2006
  • Department of Psychiatry, Compulsive, Impulsive, and Anxiety Disorders Program, USA. 2002 - 2005
  • Seaver and New York Autism Center of Excellence, New York, NY 10029, USA. 2005
  • Mt. Sinai School of Medicine, One Gustave Levy Place, Box 1230, NY, NY 10029, USA. 2005

References

  1. FDG-PET study in pathological gamblers. 1. Lithium increases orbitofrontal, dorsolateral and cingulate metabolism. Hollander, E., Buchsbaum, M.S., Haznedar, M.M., Berenguer, J., Berlin, H.A., Chaplin, W., Goodman, C.R., LiCalzi, E.M., Newmark, R., Pallanti, S. Neuropsychobiology (2008) [Pubmed]
  2. Should OCD leave the anxiety disorders in DSM-V? The case for obsessive compulsive-related disorders. Hollander, E., Braun, A., Simeon, D. Depress. Anxiety (2008) [Pubmed]
  3. Oxytocin increases retention of social cognition in autism. Hollander, E., Bartz, J., Chaplin, W., Phillips, A., Sumner, J., Soorya, L., Anagnostou, E., Wasserman, S. Biol. Psychiatry (2007) [Pubmed]
  4. Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder. Hollander, E., Soorya, L., Wasserman, S., Esposito, K., Chaplin, W., Anagnostou, E. Int. J. Neuropsychopharmacol. (2006) [Pubmed]
  5. A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder. Hollander, E., Wasserman, S., Swanson, E.N., Chaplin, W., Schapiro, M.L., Zagursky, K., Novotny, S. J. Child. Adolesc. Psychopharmacol (2006) [Pubmed]
  6. A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Hollander, E., Phillips, A., Chaplin, W., Zagursky, K., Novotny, S., Wasserman, S., Iyengar, R. Neuropsychopharmacology (2005) [Pubmed]
  7. Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?. Hollander, E., Pallanti, S., Allen, A., Sood, E., Baldini Rossi, N. Am. J. Psychiatry (2005) [Pubmed]
  8. Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder. Hollander, E., Swann, A.C., Coccaro, E.F., Jiang, P., Smith, T.B. Am. J. Psychiatry (2005) [Pubmed]
  9. Pharmacological treatments of pathological gambling. Hollander, E., Sood, E., Pallanti, S., Baldini-Rossi, N., Baker, B. J. Gambl. Stud (2005) [Pubmed]
  10. Striatal volume on magnetic resonance imaging and repetitive behaviors in autism. Hollander, E., Anagnostou, E., Chaplin, W., Esposito, K., Haznedar, M.M., Licalzi, E., Wasserman, S., Soorya, L., Buchsbaum, M. Biol. Psychiatry (2005) [Pubmed]
  11. Imaging monetary reward in pathological gamblers. Hollander, E., Pallanti, S., Baldini Rossi, N., Sood, E., Baker, B.R., Buchsbaum, M.S. World J. Biol. Psychiatry (2005) [Pubmed]
  12. Neurological soft signs as predictors of treatment response to selective serotonin reuptake inhibitors in obsessive-compulsive disorder. Hollander, E., Kaplan, A., Schmeidler, J., Yang, H., Li, D., Koran, L.M., Barbato, L.M. J. Neuropsychiatry. Clin. Neurosci (2005) [Pubmed]
  13. Impact of recent findings on study design of future autism clinical trials. Hollander, E., Phillips, A., King, B.H., Guthrie, D., Aman, M.G., Law, P., Owley, T., Robinson, R. CNS. Spectr (2004) [Pubmed]
  14. Beyond refractory obsessions and anxiety states: toward remission. Hollander, E., Zohar, J. J. Clin. Psychiatry (2004) [Pubmed]
  15. Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders. Hollander, E., Novotny, S., Hanratty, M., Yaffe, R., DeCaria, C.M., Aronowitz, B.R., Mosovich, S. Neuropsychopharmacology (2003) [Pubmed]
  16. Obsessive-compulsive behaviors in parents of multiplex autism families. Hollander, E., King, A., Delaney, K., Smith, C.J., Silverman, J.M. Psychiatry. Res (2003) [Pubmed]
  17. A double-blind, placebo-controlled trial of clonazepam in obsessive-compulsive disorder. Hollander, E., Kaplan, A., Stahl, S.M. World J. Biol. Psychiatry (2003) [Pubmed]
  18. Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders. Hollander, E., Tracy, K.A., Swann, A.C., Coccaro, E.F., McElroy, S.L., Wozniak, P., Sommerville, K.W., Nemeroff, C.B. Neuropsychopharmacology (2003) [Pubmed]
  19. Venlafaxine in treatment-resistant obsessive-compulsive disorder. Hollander, E., Friedberg, J., Wasserman, S., Allen, A., Birnbaum, M., Koran, L.M. J. Clin. Psychiatry (2003) [Pubmed]
  20. A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder. Hollander, E., Koran, L.M., Goodman, W.K., Greist, J.H., Ninan, P.T., Yang, H., Li, D., Barbato, L.M. J. Clin. Psychiatry (2003) [Pubmed]
  21. Targeted treatments for symptom domains in child and adolescent autism. Hollander, E., Phillips, A.T., Yeh, C.C. Lancet (2003) [Pubmed]
  22. Risperidone augmentation in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. Hollander, E., Baldini Rossi, N., Sood, E., Pallanti, S. Int. J. Neuropsychopharmacol. (2003) [Pubmed]
  23. Acute and long-term treatment and prevention of relapse of obsessive-compulsive disorder with paroxetine. Hollander, E., Allen, A., Steiner, M., Wheadon, D.E., Oakes, R., Burnham, D.B. J. Clin. Psychiatry (2003) [Pubmed]
  24. Refractory obsessive-compulsive disorder: state-of-the-art treatment. Hollander, E., Bienstock, C.A., Koran, L.M., Pallanti, S., Marazziti, D., Rasmussen, S.A., Ravizza, L., Benkelfat, C., Saxena, S., Greenberg, B.D., Sasson, Y., Zohar, J. J. Clin. Psychiatry (2002) [Pubmed]
  25. A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. Hollander, E., Allen, A., Lopez, R.P., Bienstock, C.A., Grossman, R., Siever, L.J., Merkatz, L., Stein, D.J. J. Clin. Psychiatry (2001) [Pubmed]
  26. An open trial of divalproex sodium in autism spectrum disorders. Hollander, E., Dolgoff-Kaspar, R., Cartwright, C., Rawitt, R., Novotny, S. J. Clin. Psychiatry (2001) [Pubmed]
  27. New developments in impulsivity. Hollander, E., Evers, M. Lancet (2001) [Pubmed]
  28. Pharmacotherapy for obsessive-compulsive disorder. Hollander, E., Kaplan, A., Allen, A., Cartwright, C. Psychiatr. Clin. North Am. (2000) [Pubmed]
 
WikiGenes - Universities